We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Toxic interactions between fluoxetine and microplastics in zebrafish embryonic development
Summary
Researchers studied the combined toxic effects of the antidepressant fluoxetine and microplastics on zebrafish embryos at concentrations found in the environment. They found that the mixture caused more severe harm than either substance alone, including pericardial swelling, spinal deformities, delayed hatching, and increased mortality. The study suggests that microplastics and pharmaceutical pollutants may interact in waterways to create compounding threats to developing fish.
The increasing use of antidepressants, especially fluoxetine (FLX), has resulted in their presence in aquatic environments due to wastewater discharges from municipal, industrial, and hospital sources. Simultaneously, microplastics (MPs) have been extensively studied in short-term (acute) exposures, showing adverse effects such as oxidative stress, behavioral alterations and neurotoxicity. However, the embryotoxic and teratogenic effects of these compounds, as well as their impacts on the survival, development, morphology, behavior, and reproduction of fish embryos in aquatic ecosystems, remain limited. This study evaluated the toxic effects of FLX (5, 40 ng/L), MPs (25, 100 particles/L) and their mixtures (FLX-MPs) at environmentally relevant concentrations. Microscopic characterization of fluorescent MPs was performed, and their presence was evaluated in Danio rerio embryos at 24 and 96 hpf, observing their localization in the chorion. In embryotoxicity and teratogenesis tests, FLX (100 ng/L) increased the rate of malformations, including deformations of the spine (CD), tail (TM) and hypopigmentation (H); MPs induced scoliosis (S), tail deformation (TM), incomplete hatching (IE) and a dose-dependent increase in malformations. FLX-MPs mixtures caused pericardial edema (PE), tail and spine deformation, delayed hatching (HR) and increased mortality. Oxidative damage analysis showed that FLX (40 ng/L) dose-dependently increased SOD and CAT activities, with an increase in cellular oxidation biomarkers (LPX, POX, HPX). Besides, MPs (100 particles/L) showed similar effects, with increased SOD, CAT, POX and HPX activities. The FLX-MPs mixture showed the most pronounced response. In gene expression, FLX (5, 40 ng/L) modulated genes such as bax, blc2 and casp3. MPs (25, 100 particles/L) induced the expression of bax, blc2, p53 and casp3. FLX-MPs mixtures (25 particles/L-40 ng/L, 100 particles/L-40 ng/L) expressed nfr1, p53, nfe2l2a and casp3. Histological damage revealed abnormal muscle fibers (AMF) and yolk sac edema (YSE) at 40 ng/L FLX, and lamellar fusion (LF) and scoliosis (S) in MPs (100 particles/L). Brain swelling (IBT) and neuromast loss (NL) were detected in FLX-MPs mixtures. In conclusion, both FLX and MPs and their combinations affect the embryonic development and physiological state of Danio rerio.
Sign in to start a discussion.
More Papers Like This
Medicine designed to combat diseases of affluence affects the early development of fish. How do plastic microparticles contribute?
Researchers studied whether microplastic particles enhance the toxicity of three pharmaceuticals (metoprolol, enalapril, and another drug of affluence) to early fish development, examining combined effects on embryo and larval zebrafish. The results revealed that microplastics can modify the toxic effects of pharmaceuticals on fish, with implications for cumulative risk assessment in aquatic environments.
Combined exposure to microplastics and amitriptyline caused intestinal damage, oxidative stress and gut microbiota dysbiosis in zebrafish (Danio rerio)
Researchers exposed zebrafish to microplastics and the antidepressant amitriptyline, both separately and combined, and found that the mixture caused the most severe intestinal damage and gut microbiome disruption. The microplastics appeared to absorb the drug and deliver higher concentrations to gut tissue. This highlights how microplastics can act as carriers for pharmaceutical pollutants, potentially amplifying their toxic effects on aquatic life.
Toxicological Response of Zebrafish Exposed to Cocktails of Polymeric Materials and Valproic Acid
Researchers exposed adult zebrafish to polyethylene and polypropylene microplastics combined with the pharmaceutical valproic acid to study their combined effects. They found that the mixture caused measurable changes in brain enzyme activity, oxidative stress markers, and swimming behavior compared to individual exposures. The study suggests that the combination of microplastic pollution and pharmaceutical contamination in waterways may produce compounding harmful effects on aquatic life.
Toxicological Response of Zebrafish Exposed to Cocktails of Polymeric Materials and Valproic Acid
Researchers exposed adult zebrafish to microplastics made of polyethylene and polypropylene, both alone and in combination with the pharmaceutical drug valproic acid. They observed changes in social behavior, swimming performance, and aggression levels, with certain mixtures producing effects worse than either substance alone. The study suggests that microplastics and pharmaceutical pollutants together in waterways could pose compounding behavioral risks to fish.
Amitriptyline ecotoxicity in Danio rerio (Hamilton, 1822) embryos – similar toxicity profile in the presence of nanoplastics
Researchers investigated how polystyrene nanoplastics interact with the antidepressant amitriptyline and their combined toxicity to zebrafish embryos. They found that nanoplastics did not significantly alter the drug's toxicity for most endpoints, but the combination produced unexpected behavioral effects including reduced activity that differed from either substance alone. The study highlights the complexity and unpredictability of nanoplastic-pharmaceutical interactions in aquatic environments.